Indonesia-listed laboratory chain PT Diagnos Laboratorium Utama (Diagnos) plans to acquire a 97% stake, worth $24 million, in the DNA testing platform ASA Ren through a rights issue, according to a disclosure published on the Indonesia Stock Exchange (IDX) on Wednesday.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
